3D Printing Replicates Super-Soft Body Tissue Like Brain, Lungs
Imperial College London researchers have developed a new method for creating 3D structures using cryogenics (freezing) and 3D printing techniques.
This builds on previous research but is the first to create structures that are soft enough to mimic the mechanical properties of organs such as the brain and lungs. Their technique, created in collaboration with Kings College London, is published in the journal Scientific Reports.
Being able to match the structure and softness of body tissues means that these structures could be used in medical procedures to form scaffolds that can act as a template for tissue regeneration, where damaged tissues are encouraged to regrow.
Regenerating damaged tissue by ‘seeding’ porous scaffolds with cells and encouraging them to grow allows the body to heal without the issues that normally affect tissue-replacing transplant procedures, such as rejection by the body.
The use of scaffolds is becoming more common and varied in its applications, but this new technique is special in that it creates super-soft scaffolds that are like the softest tissues in the human body and could help to promote this regeneration. In particular, there might be future potential in seeding neuronal cells; those involved in the brain and spinal cord.
The researchers tested the 3D-printed structures by seeding them with dermal fibroblast cells, which generate connective tissue in the skin, and found that there was successful attachment and survival.
This success, alongside previous research, could lead to further possibilities around the growth of stem cells, which is medically exciting due to their ability to change into different types of cells.
Additionally, the technique could be used to create replica body parts or even whole organs. These could be incredibly useful to scientists, allowing them to carry out experiments not possible on live subjects. They could even be used to help with medical training, replacing the need for animal bodies to practice surgery on.
Zhengchu Tan, one of the researchers from the Department of Mechanical Engineering at Imperial, said: “At the moment we have created structures a few centimetres in size, but ideally we’d like to create a replica of a whole organ using this technique.”
The technique uses solid carbon dioxide (dry ice) to rapidly cool a hydrogel ink as it is extruded from a 3D printer. After being thawed, the gel formed is as soft as body tissues, but doesn’t collapse under its own weight, which has been a problem for similar techniques in the past.
Dr Antonio Elia Forte, one of the researchers from the Department of Bioengineering at Imperial, said: “Cryogenics is the novel aspect of this technology – it uses the phase change between liquid and solid to trigger polymerisation and create super soft objects that can hold their shape. This means that the technology has a wide variety of possible uses.”
This article has been republished from materials provided by Imperial College London. Note: material may have been edited for length and content. For further information, please contact the cited source.
‘Cryogenic 3D Printing of Super Soft Hydrogels’ by Zhengchu Tan, Cristian Parisi, Lucy Di Silvio, Daniele Dini & Antonio Elia Forte is published in Scientific Reports.
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living SystemsNews
Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.